Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3193824 | Annals of Allergy, Asthma & Immunology | 2006 | 11 Pages |
Abstract
Compared with placebo use, fluticasone propionate, 88 μg administered twice daily, significantly reduced asthma exacerbations, asthma symptoms, and rescue albuterol use and was well tolerated, with no clinically relevant systemic effects, as measured by growth velocity or 12-hour urinary cortisol excretion levels.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Richard L. MD, PhD, James W. MD, Kenneth T. MD, Kathryn V. PharmD, Catherine A. BA, Wei PhD, Melissa A. PharmD, Courtney MD,